States Move to Ban “Tianeptine — Gas Station Heroin” as Doctors and Regulators Sound Alarm
Tianeptine, often called “gas station heroin,” is an unapproved opioid‑like substance sold in stores and online that has been tied to addiction, respiratory depression, overdoses and deaths, prompting urgent warnings from clinicians and federal regulators.
- Widespread but unapproved: Tianeptine is not FDA‑approved and is sold in pill, powder, salt and liquid forms under names like Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red (FDA, Mayo Clinic).
- Legal action increasing: At least fourteen states have moved to classify or ban tianeptine; Connecticut recently implemented a sale‑and‑use ban (FDA).
- Severe health risks: At recreational doses it stimulates mu‑opioid receptors, can be more potent than morphine, causes dependence and withdrawal, and has been linked to ICU admissions and fatalities (NCBI, VCU Health).
- Youth exposure and misleading marketing: Candy‑flavored formulations and deceptive “supplement” labeling increase risk to teens and patrons at gas stations, convenience stores and online (FDA).
Medical and regulatory background
Tianeptine is a tricyclic antidepressant approved for controlled therapeutic use in some countries outside the United States. It is not approved by the U.S. Food and Drug Administration and its sale here as a dietary supplement or nootropic is considered fraudulent by regulators. At recreational doses — sometimes reported as 1.3 to 250 times the therapeutic amounts used abroad — tianeptine behaves like an opioid, stimulating mu‑opioid receptors and producing strong euphoria as well as life‑threatening respiratory suppression (Mayo Clinic; NCBI).
Federal warnings and trends
FDA officials and poison control centers have tracked rising exposures and outbreaks tied to products marketed with tianeptine. In a May 2025 letter, FDA Commissioner Martin Makary warned of a growing trend that poses a special danger to youth and urged public awareness (FDA).
“The public needs to be especially aware of this dangerous product and the serious and continuing risk it poses to America’s youth,” the FDA commissioner warned.
Health risks and adverse effects
Short‑term harms reported by clinicians and poison centers include agitation, confusion, excessive drowsiness, sweating, nausea and vomiting. More severe signs include respiratory depression, dangerously low or high blood pressure, rapid heartbeat, seizures and changes in heart rhythm. When combined with opioids, alcohol or other depressants, tianeptine can precipitate coma, cardiac arrest and death (FDA; New Jersey Health Alert).
Chronic use and treatment challenges produce opioid‑like dependence with withdrawal symptoms including intense cravings, diarrhea and muscle pains. Tianeptine often escapes routine toxicology screens, complicating diagnosis and treatment in emergency departments. A 2024 cluster tied to a product called Neptune’s Fix also implicated synthetic cannabinoids, worsening outcomes including seizures and deaths; Virginia poison centers reported about one‑third of tianeptine cases in 2024 required intensive care (VCU Health; FDA).
Industry marketing, retail availability and harm to youth
Tianeptine has been marketed with false health claims — promising relief for pain, anxiety, depression, improved focus, appetite suppression or even as an aid for opioid withdrawal — and is sold in candy‑flavored formulations that appeal to young people. These products are commonly found at gas stations, convenience stores and online and often labeled as dietary supplements or “nootropics,” a practice the FDA deems deceptive and dangerous.
Connecticut’s recent move
Connecticut this month added tianeptine to its Schedule I list, banning sale and use and citing risks to people with substance‑use disorder and children attracted by candy‑like products. Lt. Gov. Susan Bysiewicz called the scheduling change “a necessary step to combat addiction” and to protect residents misled by false marketing. Connecticut joins other jurisdictions that have added substances such as kratom derivatives, nitazenes and synthetic benzodiazepines to controlled‑substance lists (FDA; New Jersey Health Alert).
Calls for national action
Emergency physicians and toxicologists warn that piecemeal state action leaves regulatory gaps. Robert Schwaner, M.D., vice chair of system clinical affairs at Stony Brook Emergency Medicine, emphasized that while low doses affect serotonin, higher doses stimulate mu‑opioid receptors and can cause lethal respiratory depression — prompting calls for national regulation (Mayo Clinic; FDA).
Political and retail pressure is growing: congressional members and public‑health leaders have urged convenience‑store associations and online marketplaces to remove these products after spikes in poison control calls. Rep. Frank Pallone and others have publicly raised concerns and sought industry cooperation (Congressional press release).
Implications for Huntington Beach, California
Public safety and youth exposure: Huntington Beach’s many convenience stores, surf shops and heavy tourist foot traffic — especially near the pier and beaches — raise the risk that candy‑flavored or flavored tianeptine products will be mistaken for harmless supplements or candy. Parents, school officials and business owners should be alert to unknown supplements sold locally (FDA).
Strain on emergency care: Local hospitals and first responders could face cases of severe sedation, respiratory depression or withdrawal. Regional reports show a meaningful share of exposures required ICU care, creating cost and capacity burdens — Huntington Beach providers should ensure protocols identify and manage unknown opioid‑like overdoses and contact poison control early (VCU Health; FDA).
Law enforcement and policy options: California has not uniformly scheduled tianeptine statewide; city leaders and county supervisors could consider ordinances restricting sale at city‑licensed retailers while state or federal action proceeds. Local law enforcement can coordinate with state attorneys general and retail associations to remove products from shelves and online listings (Congressional press release).
Prevention and public education: Protecting families and preventing substance abuse align with rapid public education: school districts, PTA groups and youth organizations should be briefed on tianeptine risks and brand names (Tianaa, ZaZa, Neptune’s Fix, Pegasus, TD Red). Faith and civic groups can help spread warnings and pressure retailers to stop sales (Mayo Clinic).
Resources and support for addiction: Residents concerned about exposure or dependence can access national resources. The Substance Abuse and Mental Health Services Administration provides a 24/7 confidential helpline in English and Spanish — see the SAMHSA National Helpline. Local clinics and treatment providers should prepare to screen patients for tianeptine use and opioid‑like withdrawal symptoms (SAMHSA; VCU Health).
Sources and reporting resources
- FDA — New “gas station heroin” (tianeptine) product trend
- Mayo Clinic — Tianeptine
- VCU Health — What you need to know about gas station heroin
- New Jersey Health Alert — Tianeptine
- NCBI research summary
- Congressional press release
- SAMHSA National Helpline
If Huntington Beach civic leaders, retailers or hospitals want local guidance, the state and federal health alerts linked above provide clinical recommendations and reporting contacts. Community action can reduce availability to youth and protect first responders from a dangerous, unapproved opioid substance circulating in retail outlets (FDA).
